Newsroom
Flag: Research
June 26, 2018 • Research
By Jan Jarvis Glucocorticoids are often used to reduce inflammation, reduce pain and treat many conditions such as allergies and rashes. But for some people, the very drugs that treats one condition can cause another: specifically, glaucoma. The condition, which affects more than 64.3 million people, is the second-leading cause of irreversible blindness in the…
June 21, 2018 • Research
By Sally Crocker While most people do everything they can to avoid mosquitos in the summer, medical entomologist Joon-Hak Lee, PhD, goes out of his way to track them down. Dr. Lee, an Associate Professor of Biostatistics and Epidemiology at the UNT Health Science Center School of Public Health, has spent the last six mosquito…
June 19, 2018 • Research
By Jan Jarvis Charles and Teresa Gonzales know what dementia does to a person. The Grand Prairie couple has lived through it with both of their mothers. “The first thing I noticed was my mother kept asking the same question over and over,” Charles said. “She’d ask something and a few minutes later, ask…
June 11, 2018 • Pharmacology and Neuroscience, Research, School of Biomedical Sciences
ByJan Jarvis For many of the 6.5 million people who live with heart failure, developing water retention related to their disease will decrease their chances of survival. Although many patients with water retention are treated with diuretics, it is not known why they develop the condition, said Tom Cunningham, PhD, Regents Professor of Physiology…
May 29, 2018 • Research, Texas College of Osteopathic Medicine
By Jan Jarvis UNT Health Science Center has joined with the international biopharmaceutical company Cerenis Therapeutics to develop HDL-based drug delivery systems for treating cardiovascular and metabolic diseases. The joint strategic partnership called the “HDL Drug Delivery Initiative” will leverage the expertise of the research team led by Andras Lacko, PhD, Professor of Physiology…
May 29, 2018 • Research, Texas College of Osteopathic Medicine
CERENIS Therapeutics (FR0012616852 – CEREN – PEA PME eligible),an international biopharmaceutical company dedicated to the discovery and development of HDL-based innovative therapies for treating cardiovascular and metabolic diseases,as well as new HDL-based vectors for targeted drug delivery in the field of oncology and HDL platform technologies, announced the signing of a strategic partnership with the…
May 16, 2018 • Research
By Jan Jarvis Compounds that could make it easier for sleep-deprived pilots to stay alert during long missions are being studied by researchers at UNT Health Science Center and Savannah State University. Researchers are also looking at how the same compound could also be used to relieve cognitive impairment associated with Gulf War Illness.…
May 10, 2018 • Pharmacology and Neuroscience
By Jan Jarvis Since 2000, Dr. Rozalyn Anderson has studied aging and how calorie restriction helps monkeys live longer, healthier lives. What she has found is monkeys who eat less than their peers get fewer diseases of aging, such as cancer and cardiovascular disease. “A smaller body means a longer life and greater health,”…
April 9, 2018 • Research
By Jan Jarvis Alissa Mirochnitchenko anticipated that her poster on survival sex, drug use and reproductive autonomy might get noticed by a few people at Research Appreciation Day. But the medical science student underestimated its appeal. “I feel like I’ve been talking all day,” she said. “I guess the title was really enticing to faculty,…
April 4, 2018 • Research, Students
By Jan Jarvis The first year Brina Snyder presented a poster for Research Appreciation Day she was nervous about what to expect. Three years and three RADs later, Snyder has learned a thing or two. “You have to practice,” she said, “The more you say it, the better you say it and the easier…
Social media